Pleomorphic xanthoastrocytoma in the multiverse of epigenomics: is it time to recognize the variants?
Open Access
- 7 June 2022
- journal article
- letter
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 10 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalActa Neuropathologica Communications, 2022
- Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic XanthoastrocytomaAmerican Journal of Surgical Pathology, 2021
- Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway AlterationsThe Oncologist, 2019
- Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceActa Neuropathologica, 2018
- Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisBrain Pathology, 2017
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas—Same Entity or First Cousins?Brain Pathology, 2015
- Anaplastic pleomorphic xanthoastrocytomaChild's Nervous System, 1997
- The New WHO Classification of Brain TumoursBrain Pathology, 1993
- The Lipid-Rich Epithelioid GlioblastornaAmerican Journal of Surgical Pathology, 1991
- Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosisA study of 12 casesCancer, 1979